About the Company
We do not have any company description for Black Diamond Therapeutics, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $BDTX News
Black Diamond Therapeutics (BDTX) Price Target Increased by 20.75% to 13.06
The average one-year price target for Black Diamond Therapeutics (NasdaqGS:BDTX) has been revised to 13.06 / share. This is ...
BDTX Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc., a clinical-stage oncology medicine company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors.
Black Diamond Therapeutics Announces Changes to Board of Directors
Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancers, today announced ...
Black Diamond Therapeutics Inc (BDTX) Stock: A Guide to the Market Trend
To wrap up, the performance of Black Diamond Therapeutics Inc (BDTX) has been better in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It is worth mentioning ...
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
CAMBRIDGE, Mass. and NEW YORK, April 03, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target ...
Black Diamond Therapeutics Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Black Diamond Therapeutics Inc Ordinary Shares
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Black Diamond Therapeutics Inc.
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...
Black Diamond Therapeutics Inc.
1 Day BDTX 6.10% DJIA -0.77% Russell 2K -1.27% Health Care/Life Sciences 0.09% ...
Loading the latest forecasts...